Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00113685 · ClinicalTrials.gov registry record · NA
Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00113685: Completed NA study, sponsored by University of Washington.
NCT00113685 is a NA study that has completed, run by University of Washington. The registered enrollment target is 209 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00113685, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness.
Interventions
- DRUG Lactated Ringer's Solution
- DRUG Hypertonic Saline-Dextran Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-03 |
| Phase | NA |
What the finished NCT00113685 record still lists
NCT00113685 is an interventional study that assigns participants to a tested intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Lactated Ringer's Solution is the first listed.
NCT00113685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00113685 about?
NCT00113685 is a clinical study titled "Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury". The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with b...
What is the current status of trial NCT00113685?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2003-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00113685?
The interventions under investigation include: Lactated Ringer's Solution (DRUG), Hypertonic Saline-Dextran Solution (DRUG).
Who is sponsoring clinical trial NCT00113685?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00113685's enrollment target sits among peer trials
209 496th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia